Rosacea – the ophthalmic perspective

References

• Cabriera VAC, Hofling-Lima AL, Mannis MJ. Ocular rosacea: a review. Arq Bras Oftalmol 2012;75:363–369
   PubMed Web of Science ®Google Scholar
• Buechner SA. Rosacea: an update. Dermatology 2005;210:100–108
   PubMed Web of Science ®Google Scholar
• Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2002;46:584–587
   PubMed Web of Science ®Google Scholar
• Crawford GH, Pelle MT, James WD. Rosacea, I: Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004;51:327–341
   PubMed Web of Science ®Google Scholar
• Akpek EK, Merchant A, Pinar V, Foster CS. Ocular rosacea: patient characteristics and follow-up. Ophthalmology 1997;104:1863–1867
   PubMed Web of Science ®Google Scholar
• Ghanem VC, Mehra N, Wong S, Mannis MJ. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea 2003;22:230–233
   PubMed Web of Science ®Google Scholar
• Wilkin JK. Rosacea, pathophysiology and treatment. Arch Dermatol 1994;130:359–362
   PubMed Web of Science ®Google Scholar
• Tisma VS, Basta-Juzbasic A, Jaganjac M, et al. Oxidative stress and ferritin expression in the skin of patients with rosacea. J Am Acad Dermatol 2009 Feb;60:270–276
   PubMed Web of Science ®Google Scholar
• Sobottka A, Lehmann P. Rosacea: new advances in pathophysiology, clinical staging and therapeutic strategies. Hautarzt 2009;60:999–1009
   PubMedGoogle Scholar
• Afonso AA, Sobrin L, Monroy DC, et al. Tear fluid gelatinase B activity correlates with IL-1alfa concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci 1999;40:2506–2512
   PubMed Web of Science ®Google Scholar
• Barton K, Monroy CD, Nava A, Pflugfelder SC. Inflammatory cytokines in tears of patients with ocular rosacea. Ophthalmology 1997;104:1868–1874
   PubMed Web of Science ®Google Scholar
• Sobrin L, Liu Z, Monroy DC, et al. Regulation of MMP-9 activity in human tear fuid and corneal epithelial culture supernatant. Invest Ophthalmol Vis Sci 2000;41:1703–1709
   PubMed Web of Science ®Google Scholar
• Määttä M, Kari O, Tervahartiala T, et al. Tear fluid levels of MMP-8 are elevated in ocular rosacea – treatment effect of oral doxycycline. Graefe’s Arch Clin Exp Ophthalmol 2006;244:957–962
   PubMed Web of Science ®Google Scholar
• Yamasaki K, Kanada K, Macleod D, et al. TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol 2011;131:688–697
   PubMed Web of Science ®Google Scholar
• Pisella PJ, Brignole F, Debbasch C, et al. Flow cytometric analysis of conjunctival epithelium in ocular rosacea and keratoconjunctivitissicca. Ophthalmology 2000;107:1841–1849
   PubMed Web of Science ®Google Scholar
• Gutierrez EL, Galarza C, Ramos W, et al. Influence of climatic factors on the medical attentions of dermatologic diseases in a hospital of Lima, Peru. An Bras Dermatol 2010;85:461–468
   PubMed Web of Science ®Google Scholar
• Jansen T, Romiti R, Kreuter A, Altmeyer P. Rosacea fulminans triggered by high-dose vitamins B6 and B12. J Eur Acad Dermatol Venereol 2001;15:484–485
   PubMed Web of Science ®Google Scholar
• Yamasaki K, Gallo RL. The molecular pathology of rosacea. J Dermatol Sci 2009;55:77–81
   PubMed Web of Science ®Google Scholar
• Gomaa AH, Yaar M, Eyada MM, Bhawan J. Lymphangiogenesis and angiogenesis in non-phymatous rosacea. J Cutan Pathol 2007;34:748–753
   PubMed Web of Science ®Google Scholar
• Smith JR, Lanier VB, Braziel RM, et al. Expression of vascular endothelial growth factor and its receptors in rosacea. Br J Ophthalmol 2007;91:226–229
   PubMed Web of Science ®Google Scholar
• Del Rosso JQ. Advances in understanding and managing rosacea: Part 1. connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema. J Clin Aesthet Dermatol 2012;5:16–25
   PubMedGoogle Scholar
• Crawford GH, Pelle M, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004;51:327–341
   PubMed Web of Science ®Google Scholar
• Lazaridou E, Giannopoulou C, Fotiadou C, et al. The potential role of microorganisms in the development of rosacea. J Dtsch Dermatol Ges 2011;9:21–25
   PubMed Web of Science ®Google Scholar
• Li J, O'Reilly N, Sheha H, et al. Correlation between ocular Demodex infestation and serum immunoreactivity to Bacillus proteins in patients with facial rosacea. Ophthalmology 2010;117:870–877
   PubMed Web of Science ®Google Scholar
• Lazaridou E, Fotiadou C, Ziakas NG, et al. Clinical and laboratory study of ocular rosacea in northern Greece. J Eur Acad Dermatol Venereol 2011;25:1428–1431
   PubMed Web of Science ®Google Scholar
• Lacey N, Delney S, Kavanagh K, Powell FC. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol 2007;157:474–481
   PubMed Web of Science ®Google Scholar
• Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol 2002;16:328–333
   PubMed Web of Science ®Google Scholar
• Szlachic A, Silwowski Z, Karczewska E, et al. Helicobacter pylori and its eradication in rosacea. J Physiol Pharmacol 1999;50:777–786
   PubMed Web of Science ®Google Scholar
• Diaz C, O'Callaghan CJ, Khan A, Allchyshyn A. Rosacea: a cutaneous marker of Helicobacter pylori infection? Results of a pilot study. Acta Derm Venereol 2003;83:282–286
   PubMed Web of Science ®Google Scholar
• Whitfeld M, Gunasingam N, Leow LJ, et al. Staphylococcus epidermidis: a possible role in the pustules of rosacea. J Am Acad Dermatol 2011;64:49–52
   PubMed Web of Science ®Google Scholar
• Solomon A, Dursun D, Liu Z, et al. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci 2001;42:2283–2292
   PubMed Web of Science ®Google Scholar
• Li DQ, Lokeshwar BL, Solomon A, et al. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res 2001;73:449–459
   PubMed Web of Science ®Google Scholar
• Barton K, Nava A, Monroy DC, Pflugfelder SC. Cytokines and tear function in ocular surface disease. Adv Exp Med Biol 1998;438:461–469
   PubMed Web of Science ®Google Scholar
• Kocak-Altintas AG, Kocak-Midillioglu I, Gul U, et al. Impression cytology and ocular characteristics in ocular rosacea. Eur J Ophthalmol 2003;13:351–359
   PubMed Web of Science ®Google Scholar
• Leonardi A, Borghesan F, Faggian D, et al. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases. Am J Ophthalmol 2000;129:151–158
   PubMed Web of Science ®Google Scholar
• Abram K, Silm H, Oona M. Prevalence of rosacea in an Estonian working population using a standard classification. Acta Derm Venereol 2010;90:269–273
   PubMed Web of Science ®Google Scholar
• Spoendlin J, Voegel JJ, Jick SS, Meier CR. A study on the epidemiology of rosacea in the U.K. Br J Dermatol 2012;167:598–605
   PubMed Web of Science ®Google Scholar
• Wilkin J, Dahl M, Detmar M, et al; National Rosacea Society Expert Committee. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2004;50:907–912
   PubMed Web of Science ®Google Scholar
• Browning DJ, Proia AD. Ocular rosacea. Surv Ophthalmol 1986;31:145–158
   PubMed Web of Science ®Google Scholar
• Miguel AI, Salgado MB, Lisboa MS, et al. Pediatric ocular rosacea: 2 cases. Eur J Ophthalmol 2012;22:664–666
   PubMed Web of Science ®Google Scholar
• Chamaillard M, Mortemousque B, Boralevi F, et al. Cutaneous and ocular signs of childhood rosacea. Arch Dermatol 2008;144:167–171
   PubMed Web of Science ®Google Scholar
• Mehra N, Wong S, Mannis MJ. The prevalence of ocular signs in acne rosacea: comparing patients from ophthalmology and dermatology clinics. Cornea 2003;22:230–233
   PubMed Web of Science ®Google Scholar
• Oltz M, Check J. Rosacea and its ocular manifestations. Optometry 2011;82:92–103
   PubMedGoogle Scholar
• Faraj HG, Hoang-Xuan T. Chronic cicatrizing conjunctivitis. Curr Opin Ophthalmol 2001;12:250–257
   PubMed Web of Science ®Google Scholar
• Alvarenga LS, Mannis MJ. Rosacea ocular. Surf Ocul 2005;3:41–58
   PubMed Web of Science ®Google Scholar
• Çetinkaya A, Okova YA. Pediatric ocular acne rosacea: long term treatment with systemic antibiotics. Am J Ophthalmol 2006;142:816–821
   PubMed Web of Science ®Google Scholar
• Dougherty JM, McCulley JP, Silvany RE, Meyer DR. The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci 1991;32:2970–2975
   PubMed Web of Science ®Google Scholar
• Ta CN, Shine WE, McCulley JP, et al. Effects of minocycline on the ocular flora of patients with acne rosacea or seborrheicblepharitis. Cornea 2003;22:545–548
   PubMed Web of Science ®Google Scholar
• Shine WE, McCulley JP, Pandya AG. Minocycline effect on meibomian gland lipids in meibomianitis patients. Exp Eye Res 2003;76:417–420
   PubMed Web of Science ®Google Scholar
• Al Arfaj K, Al Zamil W. Spontaneous corneal perforation in ocular rosacea. Middle East Afr J Ophthalmol 2010;17:186–188
   PubMedGoogle Scholar
• Gracner B, Pahor D, Gracner T. Repair of an extensive corneoscleral perforation in a case of ocular rosacea with a keratoplasty. Klin Monbl Augenheilkd 2006;223:841–843
   PubMed Web of Science ®Google Scholar